MenB Vaccine: Implementation Via Information, Empowerment and Accessibility

Status:	Completed
Conditions:	Vaccines
Therapuetic Areas:	Immunology / Infectious Diseases
Healthy:	No
Age Range:	16 - 99
Updated:	10/4/2018
Start Date:	December 2016
End Date:	September 17, 2018

Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.

As part of an effort to increase MenB vaccine uptake among adolescents and young adults,
study teams will conduct qualitative research to maximize the effectiveness of nationally
recommended MenB educational materials. In this study, Study Teams will assess local barriers
to MenB vaccination by conducting focus groups with parents, students, and health care
professionals.

Participants (parents of 16-23 year old teens and young adults, high school and college
students 16-23 years old, and health care professionals for 16-23 year olds) will be asked to
share their thoughts on the completeness of nationally recommended and publicly available
MenB vaccine educational materials in addressing hesitations to receipt of the MenB vaccine.
There is no risk in discussing reactions to educational materials. The biggest risk is
disclosure of information provided in the study which will be reactions to health-promotion
material.

Inclusion Criteria:

- Must be able to provide informed consent or assent

Exclusion Criteria:

- Inability to provide informed consent or assent

We found this trial at

sites

University of Florida

Gainesville, Florida 32610

(352) 392-3261